FDA Revokes Avastin Approval for Breast Cancer - OncologySTAT
Links shared publicly online about this topic.
- 0total visits
FDA Revokes Avastin Approval for Breast Cancer - OncologySTAT
View full resource at oncologystat.com
Tags: Cancer, Breast Cancer, Colorectal Cancer Medication, Women's Health, FDA, Avastin, News, Medical
Most Recently Shared on November 18, 2011 at 6:52 pm By:
Breaking News: FDA Revokes Avastin Approval for Breast Cancer http://t.co/SBhWlPfj
New Avastin tests add to confusion over use in breast cancer - latimes.com
latimes.com — “After the FDA pulled its approval for Avastin in metastatic breast cancer cases in November, a couple of new studies offer hints of hope for its use in early-stage breast cancer.” View full resource at latimes.com
Most Recently Shared on January 28, 2012 at 3:09 am By:
Google News: New Avastin tests add to confusion over use in breast cancer - Los Angeles: http://t.co/U49t1gMv Full http://t.co/sJPQq0Rn
Wendy Harpham on Healthy Survivorship: Revoking FDA Approval: Conclusion
wendyharpham.typepad.com — “The FDA revokes approval of Avastin for breast cancer. What's a survivor to do? Healthy Survivors look at things the way they are. Not the way they think things should...” View full resource at wendyharpham.typepad.com
Most Recently Shared on January 13, 2012 at 5:18 am By:
Wendy Harpham on Healthy Survivorship: Revoking Avastin: Right or Wrong? - Part VIII
wendyharpham.typepad.com — “The case of the FDA revoking approval of Avastin for the treatment of breast cancer is complicated by the urgency of the need for better therapies. We’re not talking about...” View full resource at wendyharpham.typepad.com
Most Recently Shared on January 6, 2012 at 3:56 am By:
Revoking Avastin: Right or Wrong? - Part VIII http://t.co/flAJK3xb
Avastin Disappoints Against Ovarian Cancer Too | Healthland | TIME.com
healthland.time.com — “Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.” View full resource at healthland.time.com
Most Recently Shared on December 29, 2011 at 3:57 pm By:
After loss of breast-cancer approval, Avastin disappoints for ovarian cancer too | http://t.co/Y0XONZzv
Wendy Harpham on Healthy Survivorship: Revoking FDA Approval: Right or Wrong - Part III
wendyharpham.typepad.com — “In my November 28th and December 3rd posts I introduced the media storm regarding the FDA's recent revocation of approval of Avastin for the treatment of breast cancer. Today I'll...” View full resource at wendyharpham.typepad.com
Most Recently Shared on December 13, 2011 at 6:09 pm By:
Revoking FDA Approval: Right or Wrong - Part III http://t.co/B3l2GsMW
Wendy Harpham on Healthy Survivorship: Revoking FDA Approval: Right or Wrong? Part II
wendyharpham.typepad.com — “To judge the FDA's recent revocation of approval for Avastin for breast cancer, let's go back to basics. What is the job of the FDA? To find out, you need...” View full resource at wendyharpham.typepad.com
Most Recently Shared on December 4, 2011 at 2:11 am By:
Revoking FDA Approval: Right or Wrong? Part II http://t.co/29PollwI
Susan G. Komen for the Cure | FDA Revokes Avastin’s Approval for Breast Cancer
ww5.komen.org — “Susan G. Komen for the Cure | FDA Revokes Avastin’s Approval for Breast Cancer” View full resource at ww5.komen.org
Most Recently Shared on December 2, 2011 at 8:15 pm By:
Have you been following the Avastin+FDA dialogue? @komenforthecure has been, here's what they have to say about it: http://t.co/PJZrpit1
NCI Cancer Bulletin for November 29, 2011 - National Cancer Institute
cancer.gov — “NCI Cancer Bulletin for November 29, 2011 - National Cancer Institute” View full resource at cancer.gov
Most Recently Shared on December 1, 2011 at 6:24 pm By:
FDA commissioner revokes approval of bevacizumab for metastatic breast cancer http://t.co/KoYRIDxL
Wendy Harpham on Healthy Survivorship: Revoking FDA Approval: Right or Wrong?
wendyharpham.typepad.com — “Recently the FDA revoked approval of a best-selling drug, Avastin, for treatment of breast cancer. Ever since, arguments for and against the removal have been voiced in blogs and major...” View full resource at wendyharpham.typepad.com
Most Recently Shared on November 29, 2011 at 5:02 am By:
Avastin approval for breast cancer pulled - Health - CBC News
cbc.ca — “Health Canada has revoked approval of Avastin as a treatment for metastatic breast cancer, following closely in the footsteps of the U.S. Food and Drug Administration.” View full resource at cbc.ca
Most Recently Shared on November 29, 2011 at 12:42 am By:
Health Canada pulls approval of Avastin for breast cancer http://t.co/kWDn6bMo
Health Canada says Avastin should no longer be used for metastatic breast cancer - Yahoo! News
ca.news.yahoo.com — “From Yahoo! News: TORONTO - Health Canada has revoked approval of Avastin as a treatment for metastatic breast cancer, following closely in the footsteps of the U.S. Food and Drug Administration.” View full resource at ca.news.yahoo.com
Most Recently Shared on November 28, 2011 at 11:12 pm By:
Health Canada says Avastin should no longer be used for metastatic breast cancer: TORONTO - Health Canada has re... http://t.co/epFznNT4
FDA Pulls Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR
npr.org — “After more than a year of deliberations and an unprecedented public hearing in June, the agency has revoked approval of the biotech blockbuster Avastin, a medicine that chokes off the blood supply to various cancer cells, as a treatment for metastatic breast cancer.” View full resource at npr.org
Most Recently Shared on November 25, 2011 at 8:15 pm By:
FDA Pulls Approval Of Avastin For Breast Cancer, Dr. Sekeres weighs in. http://t.co/pKxnsPEt @nprhealth
Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says - Businessweek
businessweek.com — “U.S. regulators revoked approval of Roche AG’s Avastin as a treatment for metastatic breast cancer, a move the drugmaker has said could put as much as 800 million Swiss francs ($873 million) in revenue at risk.” View full resource at businessweek.com
Most Recently Shared on November 24, 2011 at 1:49 am By:
Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says: U.S. regulators revoked approval of Roche AG’s Avast... http://t.co/wiOduoUi
Health Notes: Ovarian cancer advocates concerned about FDA's stance on Avastin: While breast cancer advocates ha... http://t.co/Xn9dTek3
dailypress.com — “ While breast cancer advocates have accepted the FDA's removal of Avastin as an approved treatment for breast cancer, those advocating for ovarian cancer patients are concerned with the possible ramifications. The Ovarian Cancer National Alliance released the following statement last week:” View full resource at dailypress.com
Most Recently Shared on November 23, 2011 at 6:48 pm By:
Health Notes: Ovarian cancer advocates concerned about FDA's stance on Avastin: While breast cancer advocates ha... http://t.co/Xn9dTek3
Breast cancer patient speaks out about FDA revoking Avastin appr - KFVS12 News & Weather Cape Girardeau, Carbondale, Poplar Bluff
kfvs12.com — “Last week, the Food and Drug Administration revoked its approval of the drug Avastin for treatment of breast cancer. Now, Julie Heppe, a Sikeston woman battling cancer, speaks out about her experie” View full resource at kfvs12.com
Most Recently Shared on November 23, 2011 at 3:53 am By:
Breast cancer patient speaks out about FDA revoking Avastin approval: Last week, the Food and Drug Administratio... http://t.co/LDEnWcNZ
Advertisement

